Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8Sarcoma 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Liver Neoplasms 2Central Nervous System Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms, Glandular and Epithelial 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

pembrolizumab 2entinostat 2sipuleucel-T 1palbociclib 1luprolide acetate gel depot 1ixabepilone 1Taxes 1Pemetrexed 1Paclitaxel 1Leuprolide 1Cisplatin 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Glandular and Epithelial × ixabepilone × Genitourinary × Clear all
NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Cedars-Sinai Medical Center

Phase 2 Terminated
11 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡